David A Wohl MD
HIV/AIDS Medicine
Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine
Join to view full profile
101 Manning DrChapel Hill, NC 27514
Phone+1 984-974-7198
Fax+1 984-974-4587
Dr. Wohl is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- David Wohl, MD, is an infectious disease specialist based in Chapel Hill, NC, with a subspecialty in HIV/AIDS medicine. He completed his internal medicine residency at Duke University Hospital and a fellowship in infectious disease at the University of North Carolina Hospitals. Dr. Wohl has significant experience with emerging infectious diseases and has contributed to several publications, including studies on HIV treatment efficacy, COVID-19, and Ebola virus. He is also involved in clinical trials focusing on HIV treatment and immune modulation in individuals on suppressive ART.
Education & Training
University of North Carolina HospitalsFellowship, Infectious Disease, 1994 - 1997
Duke University HospitalResidency, Internal Medicine, 1991 - 1994
Rutgers Robert Wood Johnson Medical SchoolClass of 1991
Certifications & Licensure
NC State Medical License 1994 - 2027
American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy
- A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible
- A Study of Patients With AIDS Syndrome
Publications & Presentations
PubMed
- Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-Elicited SARS-CoV-2 Immune Responses.Davey M Smith, Isabelle R Weir, Sydney Ramirez, Camila H Coelho, Jennifer Manne-Goehler
The Journal of Infectious Diseases. 2026-08-03 - Bacterial Infection in Ebola Virus Disease, Marburg Virus Disease, Crimean-Congo Hemorrhagic Fever, and Lassa Fever.Brady Page, Elizabeth Moreton, David A Wohl, William A Fischer 2nd
Open Forum Infectious Diseases. 2026-08-01 - 1 citationsIncidence and Severity of Postacute Sequelae of SARS-CoV-2 Infection in the Omicron Era: A Prospective Cohort Study.Dan-Yu Lin, Melissa A Mischell, Xinyu Zhang, Katie R Mollan, Ning Zhang
The Journal of Infectious Diseases. 2026-06-16
Press Mentions
What to Know About the New HIV Medication BixlenvoSeptember 10th, 2026- Measles Outbreaks Are Costing the U.S. Millions of Dollars. The True Losses Can't Be CountedMarch 1st, 2026
- Newsworthy from the School of Medicine, Week of September 19 – September 25September 24th, 2025
Grant Support
- The Protective and Pathologic Features of the LASV Immune Response (LASV Legacy)UNIV OF NORTH CAROLINA CHAPEL HILL2026–2031
- The Protective and Pathologic Features of the EVD Survivor Immune SystemUNIV OF NORTH CAROLINA CHAPEL HILL2023–2028
- University of North Carolina Global HIV Prevention and Treatment Clinical Trials UnitUNIV OF NORTH CAROLINA CHAPEL HILL2007–2027
- HIV PrEP Perspectives of Liberian Adolescent Girls and Young Women and their ProvidersUNIV OF NORTH CAROLINA CHAPEL HILL2023–2026
- Patient and Provider perspectives on long acting injectable ARTUNIV OF NORTH CAROLINA CHAPEL HILL2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: